Brokerage firm Deutsche Bank Maintains its rating on Allergan plc Ordinary Shares(NYSE:AGN). In a research note issued to the investors, the brokerage major Lowers the price-target to $278.00 per share. The shares have been rated Buy. The rating by Deutsche Bank was issued on Aug 9, 2016.
In a different note, Credit Suisse said it Initiates Coverage on Allergan plc Ordinary Shares, according to a research note issued on Jul 25, 2016. The shares have been rated ‘Outperform’ by the firm.
Allergan plc Ordinary Shares (AGN) made into the market gainers list on Wednesdays trading session with the shares advancing 0.04% or 0.11 points. Due to strong positive momentum, the stock ended at $253.3, which is also near the day’s high of $255.31. The stock began the session at $254 and the volume stood at 34,32,228 shares. The 52-week high of the shares is $325 and the 52 week low is $195.5. The company has a current market capitalization of $100,295 M and it has 39,59,52,200 shares in outstanding.
Allergan plc Ordinary Shares(AGN) last announced its earnings results on Aug 8, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $3.69B. Analysts had an estimated revenue of $4.11B. Earnings per share were $3.35. Analysts had estimated an EPS of $3.35.
Several Insider Transactions has been reported to the SEC. On Jun 6, 2016, Maria Teresa Hilado (CFO) purchased 661 shares at $241.57 per share price.Also, On May 12, 2016, Nesli Basgoz (director) sold 459 shares at $225.10 per share price.On Aug 24, 2015, Brent L Saunders (CEO) purchased 1,000 shares at $301.94 per share price, according to the Form-4 filing with the securities and exchange commission.